pev3a
Vaccineexperimental
Clinical trial activity
1 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2005 (NCT00408668)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Plasmodium falciparumImmunity, active
Plasmodium falciparum immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- malaria vaccine
- pev3a
- pev3a
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00408668 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2005 | Medical Research Council, Pevion Biotech Ltd, United States Army, University of Basel, University of Oxford |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Medical Research Council | Government | 1 | 0 | 1 | 2005 |
| Pevion Biotech Ltd | For profit | 1 | 0 | 1 | 2005 |
| United States Army | Government | 1 | 0 | 1 | 2005 |
| University of Basel | Academic/Hospital | 1 | 0 | 1 | 2005 |
| University of Oxford | Academic/Hospital | 1 | 1 | 1 | 2005 |
5 organizations
Page 1 / 1